Related Experiment Video
Updated: Jan 10, 2026

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
Structure, Function, Pathomechanisms and Targeting of TDP-43 in Neurodegeneration
Xudong Zhang1, Baiwen Zhang1, Yaxin Shang2
1The First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China; The First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
TDP-43 protein alterations are linked to neurodegenerative diseases. Modifications cause TDP-43 to aggregate pathologically, impacting neuronal function and disease onset.
Area of Science:
- Neurobiology
- Molecular Biology
- Genetics
Background:
- The TAR DNA-binding protein (TDP-43) is implicated in the etiology of neurodegenerative disorders.
- Understanding TDP-43's role is crucial for developing effective treatments for these conditions.
Purpose of the Study:
- To analyze the biological and pathological effects of TDP-43 protein modifications in neurodegenerative diseases.
- To explore TDP-43's involvement in neuronal growth, axon guidance, and synaptic activity.
- To outline potential treatment strategies and future research directions.
Main Methods:
- Analysis of TDP-43 protein structure, modifications, and RNA function.
- Investigation of TDP-43's biological effects, including oxidative stress, inflammation, and autophagy.
- Examination of TDP-43's association with neuronal development and function.
Main Results:
- TDP-43 undergoes conformational and functional changes via phosphorylation, ubiquitination, SUMOylation, and acetylation.
- These modifications promote TDP-43 nuclear export and pathological aggregation.
- TDP-43 is involved in oxidative stress, inflammatory response, autophagy, and angiogenesis.
- TDP-43 directly impacts neuronal growth, axon guidance, and synaptic activity.
Conclusions:
- Altered TDP-43 protein contributes to the pathogenesis of neurodegenerative diseases.
- Targeting TDP-43 modifications and aggregation may offer therapeutic potential.
- Further research into TDP-43's mechanisms can guide the development of novel treatments.
More Related Videos
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Lysosomal Hydrolases
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...